
Targeting senescent-cell inflammation (senomorphics) may beat killing the cells
Louis says senescent cells cause multiple diseases including CVD and argues that shutting off their inflammation may be better than senolytics. Mayo researchers found a mitochondrial pathway driving this inflammation.
